Condition

Transient Ischemic Attack

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 20 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials20
Recruiting2
Common interventions20
Lead sponsors shown15
Advertisement

Clinical trials

20 shown
A Novel Rural Integrated Care and Early Prevention Model for Older Adults at High Risk of or Living With Stroke in ChinaNCT07628283 · 2026-06-01
RECRUITING
Empowerment and Mobile Technology in the Control of Cardiovascular Risk Factors in Patients With Ischemic StrokeNCT03710902 · 2018-10-17
RECRUITING
Mobility Assessment in Multi-morbidityNCT06473168 · 2024-12-01
UNKNOWN
European Blood Pressure Intensive Control After StrokeNCT04647292 · 2024-05-02
UNKNOWN
Improving How Older Adults at Risk for Cardiovascular Outcomes Are Selected for Care CoordinationNCT05820295 · 2023-05-17
COMPLETED
DELPHI in Subjects at Risk for Stroke and DementiaNCT03884647 · 2020-04-01
COMPLETED
Liraglutide in Acute Minor Ischemic Stroke or High-risk Transient Ischemic Attack Patients With Type 2 Diabetes MellitusNCT03948347 · 2019-06-25
UNKNOWN
TEC4Home Stroke - Feasibility of Home Telemonitoring Technology in Managing Hypertension Among Stroke/TIA PatientsNCT03712033 · 2018-03-01
COMPLETED
Fimasartan Blood Pressure Lowering After Acute StrokeNCT03231293 · 2016-07-28
COMPLETED
Understanding the Role of Autoimmune Disorders on the Initial Presentation of Cardiovascular DiseaseNCT02062021 · 2014-01-01
UNKNOWN
Ethnicity and Onset of Cardiovascular Disease: A CALIBER StudyNCT02176174 · 2013-12-01
COMPLETED
Optimal Blood Pressure and Cholesterol Targets for Preventing Recurrent Stroke in HypertensivesNCT01563731 · 2013-04-01
COMPLETED
Center for Stroke Disparities Solution - Community Transitions InterventionNCT01918891 · 2012-09-01
COMPLETED
Heart Rate and Initial Presentation of Cardiovascular Diseases (Caliber)NCT01947361 · 2012-01-01
UNKNOWN
Social Deprivation and Initial Presentation of 12 Cardiovascular Diseases: a CALIBER StudyNCT01937065 · 2012-01-01
UNKNOWN
Copeptin for Risk Stratification in Acute Stroke Patients: the CoRisk StudyNCT00878813 · 2009-03-01
COMPLETED
Diagnosis and Treatment of Sleep Apnea in Cerebrovascular DiseaseNCT00984308 · 2008-12-23
COMPLETED
The PREVENTS Trial: The Preventing Recurrent Events in Veterans Navigating Transient Ischemic Attack (TIA) or Stroke TrialNCT01020851 · 2008-09-01
COMPLETED
The "COSMOS"-Study (Copeptin in Osmoregulation and Stress Assessment)NCT00390962 · 2006-11-01
COMPLETED
Risk Factors in the Initial Presentation of Specific Cardiovascular Disease SyndromesNCT01804439 · 1997-01-01
COMPLETED

Common interventions

Mapped drugs appearing in these trials

Shared trial participation only; not evidence of efficacy or approval.

Leading sponsors

Trial status mix

COMPLETED12
UNKNOWN6
RECRUITING2

Phase mix

NA6
PHASE22
PHASE31
PHASE41
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.